期刊
NATURE REVIEWS CANCER
卷 13, 期 10, 页码 714-726出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3599
关键词
-
类别
资金
- Cancer Research UK [C212/A13721]
- Cancer Research UK [13172, 13721] Funding Source: researchfish
- Public Health Agency [RRG/3261/05] Funding Source: researchfish
Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据